Protagonist Therapeutics Files 8-K
Ticker: PTGX · Form: 8-K · Filed: Mar 20, 2025 · CIK: 1377121
Sentiment: neutral
Topics: 8-K, filing, company-info
TL;DR
Protagonist Therapeutics filed a routine 8-K, no major news.
AI Summary
On March 17, 2025, Protagonist Therapeutics, Inc. filed an 8-K report. The filing indicates that the company is a pharmaceutical preparations company incorporated in Delaware with its principal executive offices located in Newark, California. The report does not contain specific financial transactions or material events beyond its routine filing status.
Why It Matters
This 8-K filing serves as a notification to the SEC and the public about the company's status and location, which is standard for publicly traded entities.
Risk Assessment
Risk Level: low — The filing is a standard 8-K current report and does not disclose any new material events, risks, or financial changes.
Key Players & Entities
- Protagonist Therapeutics, Inc. (company) — Registrant
- March 17, 2025 (date) — Date of earliest event reported
- Newark, California (location) — Principal executive offices
- Delaware (location) — State of incorporation
FAQ
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing is March 17, 2025.
What is the principal executive office address for Protagonist Therapeutics, Inc.?
The principal executive office address is 7707 Gateway Blvd., Suite 140, Newark, California 94560-1160.
In which state is Protagonist Therapeutics, Inc. incorporated?
Protagonist Therapeutics, Inc. is incorporated in Delaware.
What is the Commission File Number for Protagonist Therapeutics, Inc.?
The Commission File Number for Protagonist Therapeutics, Inc. is 001-37852.
What is the IRS Employer Identification Number for Protagonist Therapeutics, Inc.?
The IRS Employer Identification Number for Protagonist Therapeutics, Inc. is 98-0505495.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 20, 2025 regarding Protagonist Therapeutics, Inc (PTGX).